| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |